首页> 美国卫生研究院文献>BMJ Case Reports >Case Report: High-dose tigecycline and colistin for successful treatment of disseminated carbapenem-resistant Klebsiella pneumoniae infection in a liver transplant recipient
【2h】

Case Report: High-dose tigecycline and colistin for successful treatment of disseminated carbapenem-resistant Klebsiella pneumoniae infection in a liver transplant recipient

机译:病例报告:大剂量替加环素和粘菌素可成功治疗肝移植受者中弥散性耐碳青霉烯类肺炎克雷伯菌的感染

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Solid organ transplantation (SOT) is a risk factor for the acquisition of carbapenem-resistant Klebsiella pneumoniae. This infection is associated with a high mortality rate given the limited armamentarium of antibiotics for multidrug-resistant organisms along with continued immunosuppression to prevent graft rejection. We report a case of carbapenem-resistant K. pneumoniae pneumonia, bacteraemia and intra-abdominal infection in a newly transplanted liver recipient. The patient was successfully treated with a long course of high-dose tigecycline and colistin, along with surgical drainage. We discuss SOT-relevant epidemiology, therapeutic options and the rationale for our treatment choice.
机译:实体器官移植(SOT)是获得耐碳青霉烯类肺炎克雷伯菌的危险因素。这种感染与高死亡率有关,因为对多药耐药生物的抗生素装备有限,并需要持续进行免疫抑制以防止移植排斥。我们报告了在新移植的肝受体中对碳青霉烯耐药的肺炎克雷伯氏菌肺炎,菌血症和腹腔内感染的病例。长期使用大剂量的替加环素和大肠粘菌素以及外科引流术成功治疗了该患者。我们讨论了与SOT相关的流行病学,治疗选择以及我们选择治疗的理由。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号